drug research

Combo pill effective for obesity treatment--study

According to a new study conducted by US scientists, a combination of two existing drugs has shown to be two times more effective in reducing weight than the only approved anti-obesity medicine.

Combo pill effective for obesity treatment.jpg

Dr. Kishore Gadde of the Duke University Medical Centre, in Durham, North Carolina, along with his team found a 10 percent drop in obese patients’ body weight in a year, who were given combination of phentermine, a prescribed short-term weight loss drug, and topiramate, anticonvulsant approved for treating seizure disorders and migraines.

Topiramate has lead to weight loss in obese patients with type 2 diabetes, but has been linked to cognitive and psychiatric side effects when taken alone.

FDA advisory panel to review Lilly, Daiichi's blood clotting drug

New York, United States, January 1: An experimental heart drug by two global pharmaceutical companies, Eli Lilly and Co. and Daiichi Sankyo Co., Ltd., will be reviewed by a US Food an

FDA advisory panel to review Lilly, Daiichi's blood clotting drug

Lilly and Daiichi confirmed Wednesday that FDA’s Cardiovascular and Renal Drugs Advisory Committee (CRDAC) will review their blood-clot preventer prasugrel during an advisory committee hearing on Feb. 3, 2009.

FDA approves prostate cancer drug

Rockville, United States, December 30: The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancerdefinedefine.

FDA approves prostate cancer drug

Degarelix is intended to treat patients with advanced prostate cancerdefinedefine. It belongs to a class of agents called gonadotropin, releasing hormone (GnRH) receptor inhibitors. These agents slow the growth and progression of prostate cancer by suppressing testosterone, which plays an important role in the continued growth of prostate cancer.

Syndicate content